Jabil Inc. (US) and Celestica Inc. (Canada) are Leading Players in the Diagnostic Contract Manufacturing Market
The global diagnostic contract manufacturing market is expected to reach USD 44.9 billion by 2028 from USD 26.0 billion in 2023, at a CAGR of 11.5% during the forecast period. Factors such as the increasing demand for early diagnosis, and widening scope of clinical applications, and the high cost of in-house manufacturing are expected to drive the demand for diagnostic contract manufacturing market. For instance, the cost of hematology analyzers by Sysmex ranges from ~USD 5,000 to USD 100,000, and that of Siemens may reach up to USD 500,000. However, the cost of manufacturing hematology analyzers in a CMO ranges from ~USD 3,000 to ~USD 70,000, which reduces the overall cost and ensures profit margins for large IVD companies.
The diagnostic contract manufacturing market is highly consolidated and is dominated by various players. The major players operating in this market are Jabil Inc. (US), Flex Ltd. (Singapore), Plexus Corp (US), Sanmina Corporation (US), TE Connectivity Ltd. (Switzerland), and Celestica Inc. (Canada). These include a range of initiatives, such as establishing contracts and partnerships, pursuing mergers and acquisitions, and engaging in new product development endeavors. These actions aim to enhance their position in the market for diagnostic contract manufacturing.
To know about the assumptions considered for the study download the pdf brochure
Jabil Inc.
Jabil, Inc. is the key player in the market. The company’s global presence has greatly helped it assess and execute business opportunities in diversified contract manufacturing industries. The company also serves some of the leading companies in other business sectors, which strengthens its brand recognition. In February 2020, it launched Jabil Healthcare in collaboration with Nypro (US) to deliver advanced manufacturing solutions.
Celestica Inc.
Celestica company has a robust portfolio of diagnostic contract manufacturing in its Advanced Technology Solutions Segment. In 2022, Atrenne, a Celestica company, received ISO 13485:2016 certification for medical device design. This achievement certifies the company for the design of medical products, including components, integrated assemblies, and embedded computing platforms.
Sanmina Corporation
Sanmina Corporation is a global player with a strong presence in almost 40 countries. The company focuses on technological advancements by offering electronic and custom medical devices. The company’s end-to-end solutions offer customers a single source of supply for their design, supply chain, and manufacturing needs, thus lowering product cost and delivery time. It also has great experience in serving diverse markets and meeting industry standards & regulatory requirements. For instance, in October 2022, the company formed a joint venture with Reliance (India) to prioritize high-technology infrastructure across various industries, including medical and healthcare systems.
Related Reports:
Diagnostic Contract Manufacturing Market by Device (In Vitro Diagnostic Devices and Diagnostic Imaging Devices), Service (Device Development & Manufacturing, Quality Management, and Packaging & Assembly), Application, Region - Global Forecast to 2028
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
